Cite

HARVARD Citation

    Pires Amaro, C. et al. (2022). Dosing, efficacy and safety of lenvatinb in the real‐world treatment of hepatocellular carcinoma: Results from a Canadian database. Liver Cancer International. 3 (3), pp. 119-127. [Online]. 
  
Back to record